Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
29
AVD Quote, Financials, Valuation and Earnings
Last price:
$4.26
Seasonality move
:
-3.8%
Day range:
$4.20 - $4.33
52-week range:
$3.28 - $12.67
Dividend yield:
2.84%
P/E ratio:
46.76x
P/S ratio:
0.21x
P/B ratio:
0.37x
Volume:
101K
Avg. volume:
188.7K
1-year change:
-64.15%
Market cap:
$121.5M
Revenue:
$579.4M
EPS (TTM):
-$1.03
Analysts' Opinion
-
Consensus RatingAmerican Vanguard has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.00, American Vanguard has an estimated upside of 231.75% from its current price of $4.22.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $4.22.
Fair Value
-
According to the consensus of 1 analyst, American Vanguard has 231.75% upside to fair value with a price target of $14.00 per share.
AVD vs. S&P 500
-
Over the past 5 trading days, American Vanguard has underperformed the S&P 500 by -0.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
American Vanguard does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
American Vanguard revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter American Vanguard reported revenues of $118.3M.
Earnings Growth
-
American Vanguard earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter American Vanguard reported earnings per share of -$0.91.
Enterprise value:
288.4M
EV / Invested capital:
--
Price / LTM sales:
0.21x
EV / EBIT:
26.56x
EV / Revenue:
0.52x
PEG ratio (5yr expected):
--
EV / Free cash flow:
6.00x
Price / Operating cash flow:
2.47x
Enterprise value / EBITDA:
60.55x
Gross Profit (TTM):
$152.1M
Return On Assets:
-3.69%
Net Income Margin (TTM):
-5.22%
Return On Equity:
-8.12%
Return On Invested Capital:
-5.33%
Operating Margin:
-17.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $609.7M | $566.7M | $553.8M | $149.5M | $118.3M | |
| Gross Profit | $166.8M | $166.6M | $152.1M | $43.1M | $17.3M | |
| Operating Income | $46.2M | $15.1M | -$4M | $4.2M | -$20.2M | |
| EBITDA | $70.2M | $40.3M | $4.8M | $9.3M | -$22.9M | |
| Diluted EPS | $0.95 | $0.16 | -$1.03 | -$0.01 | -$0.91 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $353M | $376.3M | $436.8M | $471.6M | $425.1M | |
| Total Assets | $675.7M | $735.9M | $776.2M | $802.8M | $759.5M | |
| Current Liabilities | $150.5M | $178.3M | $219.9M | $189.5M | $225.3M | |
| Total Liabilities | $330.9M | $367.5M | $413.6M | $444.1M | $431.6M | |
| Total Equity | $344.8M | $368.3M | $362.6M | $358.7M | $327.9M | |
| Total Debt | $149.4M | $136.3M | $148.4M | $218M | $178.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $40.9M | -$43.1M | $57.3M | -$49.3M | $26.6M | |
| Cash From Investing | -$11.6M | -$13.6M | -$14.3M | -$2M | $17K | |
| Cash From Financing | -$26M | $48.6M | -$43.1M | $48.6M | -$33.5M | |
| Free Cash Flow | $29M | -$56.9M | $48.1M | -$51.4M | $26.6M | |
AVD
Sector
Market Cap
$121.5M
$17.8M
Price % of 52-Week High
33.31%
61.91%
Dividend Yield
2.84%
0%
Shareholder Yield
1.19%
1.19%
1-Year Price Total Return
-64.15%
-15.62%
Beta (5-Year)
1.244
0.784
Dividend yield:
2.84%
Annualized payout:
$0.12
Payout ratio:
-11.56%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$4.21
200-day SMA
Sell
Level
$5.56
Bollinger Bands (100)
Sell
Level
4.14 - 5.48
Chaikin Money Flow
Buy
Level
7.7M
20-day SMA
Buy
Level
$3.98
Relative Strength Index (RSI14)
Buy
Level
51.20
ADX Line
Buy
Level
22.64
Williams %R
Neutral
Level
-36.4238
50-day SMA
Sell
Level
$4.39
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
9.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2524)
Buy
CA Score
(Annual)
Level (-0.0429)
Sell
Beneish M-Score
(Annual)
Level (-1.9566)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.7521)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
Stock Forecast FAQ
In the current month, AVD has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AVD average analyst price target in the past 3 months is $14.00.
-
Where Will American Vanguard Stock Be In 1 Year?
According to analysts, the consensus estimate is that American Vanguard share price will rise to $14.00 per share over the next 12 months.
-
What Do Analysts Say About American Vanguard?
Analysts are divided on their view about American Vanguard share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that American Vanguard is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is American Vanguard's Price Target?
The price target for American Vanguard over the next 1-year time period is forecast to be $14.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AVD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for American Vanguard is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of AVD?
You can purchase shares of American Vanguard via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase American Vanguard shares.
-
What Is The American Vanguard Share Price Today?
American Vanguard was last trading at $4.26 per share. This represents the most recent stock quote for American Vanguard. Yesterday, American Vanguard closed at $4.22 per share.
-
How To Buy American Vanguard Stock Online?
In order to purchase American Vanguard stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 113.25% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 9.89% over the past day.
